Dupharma / SCINTIMUN Granulocyte

SCINTIMUN^® 1 mg
Kit for Labelling Monoclonal Antibody (MAb) BW 250/183 with Technetium (99mTc)

Isotope	Technetium (^99mTc)
Number of labelling sets	2
Each vial 1 contains 5.02 mg dry substance : Besilesomab Disodium hydrogen phosphate, anhydrous Sodium dihydrogen phosphate, anhydrous Under nitrogen atmosphere Sorbitol E420 Each vial 2 contains 3 mg dry substance : 1,1,3,3-propane tetraphosphonic acid, tetrasodium salt, dihydrate (PTP) Tin (II) chloride dihydrate Sodium hydroxyde 1N (pH adjustment) Hydrochloric acid 1N (pH adjustment) Under nitrogen atmosphere	1 mg 1.42 mg 0.60 mg 2 mg 2.7 mg 0.12 mg
Volume of pertechnetate ^99mTc to use for reconstitution	2 to 7 mL
Radiochemical purity	≥ 95 %
Storage	2 years at 2 - 8°C
Stability of labelled product	3 h at 2-8°C Protected from light and atmospheric oxygen
Activity per vial	300 to 1800 MBq
Indications / Posology	Detection of location of infectious/inflammatory lesions (400-800 MBq) Bone marrow scintigraphy (200 - 400 MBq)
Time between injection and examination	3 to 6 h and late image 24 h
Availability	From stock